Welcure Drugs

{
  "main_header": {
    "sid": 736142,
    "name": "Welcure Drugs",
    "stock_name": "Welcure Drugs",
    "full_name": "Welcure Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/welcure-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.25",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.25",
    "mcapval": "30.90 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524661,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE331C01025",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "70.8 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs024-3902542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3902542.png",
        "date": "2026-03-20 09:41:23",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs025-3899975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3899975.png",
        "date": "2026-03-19 09:58:00",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs026-3894013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3894013.png",
        "date": "2026-03-16 12:44:42",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-amid-market-downturn-3888549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3888549.png",
        "date": "2026-03-13 09:58:45",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3873284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_mojoScore_3873284.png",
        "date": "2026-03-05 10:10:02",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3845619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WelcureDrugsPha_mojoScore_3845619.png",
        "date": "2026-02-18 10:10:25",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3841649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WelcureDrugsPha_valuationdot_3841649.png",
        "date": "2026-02-16 08:03:47",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive valuation grade. This change is underscored by its exceptionally low price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both its historical averages and peer group benchmarks, signalling a potential opportunity for value investors amid a challenging market backdrop."
      },
      {
        "title": "Welcure Drugs Gains 9.09%: Mixed Quarterly Results and Margin Pressures Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-gains-909-mixed-quarterly-results-and-margin-pressures-shape-the-week-3839794",
        "imagepath": "",
        "date": "2026-02-14 15:08:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 9:</strong> Stock opens at Rs.0.34, gains 3.03% amid positive market sentiment</p>\n                    <p><strong>Feb 10:</strong> Continued upward momentum with 2.94% gain to Rs.0.35</p>\n                    <p><strong>Feb 11:</strong> Price rises further by 2.86% to Rs.0.36</p>\n                    <p><strong>Feb 12:</strong> Stock peaks at Rs.0.37 (+2.78%) despite Sensex decline</p>\n                    <p><strong>Feb 13:</strong> Mixed quarterly results trigger 2.70% fall to Rs.0.36</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.33</div></div>\n  ..."
      },
      {
        "title": "Are Welcure Drugs & Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-welcure-drugs-pharmaceuticals-ltd-latest-results-good-or-bad-3838304",
        "imagepath": "",
        "date": "2026-02-13 20:07:28",
        "description": "The latest financial results for Welcure Drugs & Pharmaceuticals Ltd indicate significant operational challenges. In the quarter ending December 2025, the company reported net sales of ₹0.00 crores, marking a complete cessation of revenue generation compared to ₹65.62 crores in the previous quarter. This dramatic decline raises serious concerns regarding the company's operational viability.\n\nNet profit for the same quarter was reported at ₹1.07 crores, but this figure was largely driven by other income of ₹1.46 crores, which highlights a concerning dependency on non-operating income for profitability. The company incurred an operating loss of ₹0.03 crores, suggesting that its core pharmaceutical operations are not generating any revenue.\n\nThe operating margin fell to 0.0%, down from 17.31% in the prior quarter, reflecting a complete operational collapse. The return on equity (ROE) stands at 33.54%, which ap..."
      }
    ],
    "total": 288,
    "sid": "736142",
    "stock_news_url": "https://www.marketsmojo.com/news/welcure-drugs-pharmaceuticals-736142"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2026",
      "details": "Newspaper Clipping of Unaudited Financials for 3rd Quarter ended December 21 2025.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The 3Rd Quarter Ended On 31St December 2025.",
      "datetime": "12-Feb-2026",
      "details": "Unaudited Financials Results for the 3rd Quarter ended on 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Thursday 12Th February 2026",
      "datetime": "12-Feb-2026",
      "details": "Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Thursday 12th February 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24

2026-03-20 09:41:23

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25

2026-03-19 09:58:00

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26

2026-03-16 12:44:42

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn

2026-03-13 09:58:45

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-03-05 10:10:02

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-02-18 10:10:25

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-02-16 08:03:47

Welcure Drugs & Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive valuation grade. This change is underscored by its exceptionally low price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both its historical averages and peer group benchmarks, signalling a potential opportunity for value investors amid a challenging market backdrop.

Read full news article

Welcure Drugs Gains 9.09%: Mixed Quarterly Results and Margin Pressures Shape the Week

2026-02-14 15:08:37

Key Events This Week

Feb 9: Stock opens at Rs.0.34, gains 3.03% amid positive market sentiment

Feb 10: Continued upward momentum with 2.94% gain to Rs.0.35

Feb 11: Price rises further by 2.86% to Rs.0.36

Feb 12: Stock peaks at Rs.0.37 (+2.78%) despite Sensex decline

Feb 13: Mixed quarterly results trigger 2.70% fall to Rs.0.36

Week Open

Rs.0.33

...

Read full news article

Are Welcure Drugs & Pharmaceuticals Ltd latest results good or bad?

2026-02-13 20:07:28

The latest financial results for Welcure Drugs & Pharmaceuticals Ltd indicate significant operational challenges. In the quarter ending December 2025, the company reported net sales of ₹0.00 crores, marking a complete cessation of revenue generation compared to ₹65.62 crores in the previous quarter. This dramatic decline raises serious concerns regarding the company's operational viability. Net profit for the same quarter was reported at ₹1.07 crores, but this figure was largely driven by other income of ₹1.46 crores, which highlights a concerning dependency on non-operating income for profitability. The company incurred an operating loss of ₹0.03 crores, suggesting that its core pharmaceutical operations are not generating any revenue. The operating margin fell to 0.0%, down from 17.31% in the prior quarter, reflecting a complete operational collapse. The return on equity (ROE) stands at 33.54%, which ap...

Read full news article

View All News